As semaglutide prepares to go off patent in India by 2026 several pharmaceutical companies are getting ready to launch the cost effective versions of this popular weight-loss drug.
Yet amid it’s success lies and unfolding health crisis of misuse and over demand for semaglutide especially among individuals without clinical obesity. It has been observed that, individuals with normal BMI are also seeking semaglutide to lose few kilos without any underlying medical indication.This widespread off label use can not only have dangerous impacts on health but will also pave the way for the rise of black market and compounded products.
Thus it needs to be ensured that such medications are used ethically,equitably and safely.
What are your thoughts on this ?
MBH/PS